340 results on '"Feuring-Buske, Michaela"'
Search Results
2. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
3. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice
4. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis
5. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
6. Ectopic Expression of the Homeobox Gene Cdx2 Is the Transforming Event in a Mouse Model of t(12;13)(p13;q12) Acute Myeloid Leukemia
7. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
8. Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis
9. Was ist Krebs?
10. High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia
11. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
12. The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia
13. Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens
14. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)
15. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia
16. Higher Dose of CPX-351 Is Associated with Prolonged Hematologic Recovery: Results from an Interim Safety Analysis of the Randomized, Phase III AMLSG 30-18 Trial
17. Pathogenese und Biologie der akuten myeloischen Leukämie
18. Diagnostik, Klassifikation und Prognosefaktoren der akuten myeloischen Leukämie
19. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12; 13)(p13;q12) acute myeloid leukemia
20. A Core–Shell Albumin Copolymer Nanotransporter for High Capacity Loading and Two-Step Release of Doxorubicin with Enhanced Anti-Leukemia Activity
21. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia
22. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition
23. Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
24. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis
25. The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia
26. Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia
27. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice
28. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia
29. Gold Nanoparticles with Selective Antileukemic Activity In Vitro and In Vivo Target Mitochondrial Respiration
30. AML Cells Express Exclusively the Long Isoform of LEF1 and Are Highly Vulnerable to Blockage of LEF1-β-Catenin Binding
31. The Non-Canonical, R-Loop Regulatory Function of PIWIL4 Maintains Genomic Integrity and Leukemic Potential of AML Cells
32. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells
33. Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus
34. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia
35. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo
36. Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
37. Aberrantly expressed TET1 in T-ALL regulates DNA repair and leukemic growth via maintenance of 5-hydroxymethylome and can be antagonized by the parp inhibitor Olaparib
38. The dioxygenase TET3 is aberrantly high expressed in acute myeloid leukemia, promotes leukemic growth and impairs myeloid differentiation of normal hematopoietic stem progenitors
39. Aberrantly expressed stem cell associated protein PIWIL4 acts as a piRNA binding, epigenetically active and growth regulatory factor in human acute myeloid leukemia
40. DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization
41. Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications
42. The PARP Inhibitor Olaparib Antagonizes Leukemic Growth Induced By TET1 Overexpression in AML1-ETO Positive Acute Myeloid Leukemia
43. The Methylcytosine Dioxygenase TET3 Is Aberrantly Expressed in Acute Myeloid Leukemia and Promotes AML Growth
44. The Human Specific microRNA-941 Is a Key Member of a microRNA Signature of Functionally Validated Leukemic Stem Cells from Patients with Acute Myeloid Leukemia
45. TET1 Promotes Leukemic Growth in T-ALL Via Maintenance of 5-Hydroxymethylation Marks and Can be Antagonized By the PARP Inhibitor Olaparib
46. Two Long Non-Coding RNAs Are Sufficient to Classify and Significantly Predict In Vivo Engraftment Potential and LSC Properties of Human Acute Myeloid Leukemia Cells
47. DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization
48. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice
49. The ParaHox gene Cdx4induces acute erythroid leukemia in mice
50. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.